SEC 13F Intelligence

Endurant Capital Management LP / BMRN

Endurant Capital Management LP’s Biomarin Pharmaceutical Inc Position

Does Endurant Capital Management LP own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 4.7K shares worth $448,353 in Q4 2023; the fund’s latest 13F (Q1 2024) no longer reports it.

Position Value
$448,353
Q4 2023
Shares
4.7K
% of Portfolio
+2.57%
Quarters Held
8
position exited

Position History BMRN

Reported value by quarter
Q1 ’20: $2MQ1 ’20Q2 ’22: $2MQ2 ’22Q3 ’22: $12MQ3 ’22Q4 ’22: $9MQ4 ’22Q1 ’23: $25MQ1 ’23Q2 ’23: $4MQ2 ’23Q3 ’23: $16MQ3 ’23Q4 ’23: $448,353Q4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20234.7K$448,353+2.57%
Q3 2023179.6K$16M+14.27%
Q2 202343.6K$4M+3.30%
Q1 2023255.6K$25M+12.77%
Q4 202284.4K$9M+3.55%
Q3 2022145.4K$12M+4.01%
Q2 202226.0K$2M+0.76%
Q1 202028.6K$2M+1.10%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurant Capital Management LP’s full portfolio or all institutional holders of BMRN.